SID Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Despite longer-term bullish moving averages, SID just broke below its pivot on a sharp -7.52% session drop while facing fresh, headline-driven operational risk (nearby flooding/pollution incident). With no Intellectia buy signal, a sell-rated analyst view (UBS) and an implied short-term drift negative, I would avoid initiating a position here and would treat this as a sell/avoid until the news overhang clears and price reclaims key levels.
Trend/structure: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating the broader trend has been constructive. However, today’s price (1.925) is slightly below the pivot (1.929) after a steep drawdown, signaling near-term weakness and fragile momentum. Momentum: MACD histogram is positive (0.0128) but contracting, consistent with fading upside momentum. RSI(6)=46.7 is neutral, not oversold—so there’s no strong mean-reversion “must-buy” setup yet. Levels: Immediate support S1=1.731 (then S2=1.608). Resistance is R1=2.128 then R2=2.251. For an impatient buyer, the reward/risk is unfavorable while price sits below pivot with room to fall toward S1. Pattern odds provided: Similar-pattern stats imply ~40% chance of -1.36% next day and -3.25% next week (near-term negative), offset by +9.2% next month (more time-dependent).
Intellectia Proprietary Trading Signals
Gross margin improved materially in 2025/Q3 (29.21, +19.22% YoY), which can support re-rating if profitability stabilizes.
Options positioning skews more to calls than puts (PCRs < 1), hinting at some bullish bias.
If the Vale incident is confirmed to have no operational impact on CSN, relief could drive a rebound back toward 2.13 (R1).
Event-driven headline risk: news links CSN to potential flooding/disruption risk from Vale’s nearby mine water overflow; environmental/pollution concerns can pressure the stock regardless of fundamentals.
Price action is risk-off today (-7.52%), and price is below pivot with room to test lower supports (1.731/1.608).
Analyst stance is bearish: UBS maintains a Sell with a $1.40 target (below current price), reinforcing downside consensus risk.
Latest quarter: 2025/Q3. Revenue grew to 2.165B (+8.49% YoY), and gross margin improved to 29.21 (+19.22% YoY), showing better top-line and unit economics. However, profitability deteriorated sharply: Net income fell to -25.16M (-83.39% YoY) and EPS to -0.02 (-81.82% YoY). The core issue is that improved margin hasn’t translated into bottom-line strength, leaving the equity vulnerable during negative headlines.
Recent change: On 2025-12-15, UBS raised its price target slightly to $1.40 from $1.30 but kept a Sell rating. Wall Street pros: modest margin and revenue improvement can support recovery if earnings normalize. Wall Street cons: continued losses and a Sell rating with a target meaningfully below the current price suggest pros see limited near-term upside and elevated fundamental risk.
